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The N6-methylation of internal adenosines (m6A) in mRNA has been
quantified and localized throughout the transcriptome. However,
the physiological significance of m6A in most highly methylated
mRNAs is unknown. It was demonstrated previously that the circa-
dian clock, based on transcription-translation negative feedback
loops, is sensitive to the general inhibition of m6A. Here, we show
that the Casein Kinase 1 Delta mRNA (Ck1δ), coding for a critical
kinase in the control of circadian rhythms, cellular growth, and sur-
vival, is negatively regulated by m6A. Inhibition of Ck1δ mRNA
methylation leads to increased translation of two alternatively
spliced CK1δ isoforms, CK1δ1 and CK1δ2, uncharacterized until
now. The expression ratio between these isoforms is tissue-
specific, CK1δ1 and CK1δ2 have different kinase activities, and they
cooperate in the phosphorylation of the circadian clock protein
PER2. While CK1δ1 accelerates the circadian clock by promoting
the decay of PER2 proteins, CK1δ2 slows it down by stabilizing
PER2 via increased phosphorylation at a key residue on PER2 pro-
tein. These observations challenge the previously established model
of PER2 phosphorylation and, given the multiple functions and tar-
gets of CK1δ, the existence of two isoforms calls for a re-evaluation
of past research when CK1δ1 and CK1δ2 were simply CK1δ.
casein kinase | circadian | methylation | splicing | m6A
Since 2012, the N6-methylation of internal adenosines (m6A)has regained tremendous interest due to the use of affinity
immunoprecipitation of methylated mRNA coupled with next-
generation RNA-Seq (1, 2), confirming earlier reports (3, 4).
m6A accounts for 50% of all methylated nucleotides in poly-
adenylated mRNA (5) and for 80% of all base methylations (3).
It is the most prevalent internal mRNA modification in higher
eukaryotes and is widely conserved from yeast to mammals (6,
7). m6A has been involved in the regulation of mRNA splicing,
processing, and translation (8, 9) and is required for survival and
development in multiple species (10–12).
The circadian clock is composed of clock genes interlocked in
transcription-translation negative feedback loops (TTFL) regu-
lating their own expression (13). This molecular oscillator, robust
in normal conditions yet sensitive to perturbations affecting gene
expression and RNA processing, allowed us to demonstrate the
importance of m6A for its function (14), but which clock genes
are directly regulated by m6A remains unknown.
While the core TTFL has been the focus of early circadian
research, protein phosphorylation was quickly shown to be es-
sential for molecular timekeeping (15, 16). Phosphorylation of
clock proteins is mediated mainly by the Casein Kinases 1 Delta
and Epsilon. The first human inherited circadian syndrome to
be described, the Familial Advanced Sleep Phase Syndrome
(FASPS), originates from a mutated CK1δ (17) or a mutated
CK1δ-target serine in PER2 protein (18), causing early sleep
onset and offset. The first circadian mutation to be discovered in
a mammalian model is a mutation in CK1e (16, 19).
Here, we show that the 3′-UTR of Ck1δ is heavily m6A-
methylated and negatively controls the translation of two CK1δ
isoforms, uncharacterized until now. These two CK1δ isoforms
are expressed in a tissue-specific manner and antagonistically
regulate the circadian clock.
Results
The 3′-UTR of Ck1δ Is Methylated. To identify clock-related tran-
scripts regulated by m6A, we quantified m6A levels in mouse
liver mRNA at two time points, CT4 and CT16 (CT is circadian
time, and CT0 and CT12 correspond to the beginning of the rest
and the active phase, respectively). Significant m6A peaks were
found at CT4 (8,414) and at CT16 (8,821). Most peaks (72%)
were detected at both time points (Dataset S1). Several tran-
scripts involved in circadian regulation showed significant peaks
at CT4 and CT16 (SI Appendix, Fig. S1A). Since Clock (20), Dbp
(21), Ck1δ (17), and Fbxl3 (22, 23) are potent regulators of the
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circadian period, m6A methylation of these transcripts is likely to
be of importance for clock function. Of these four transcripts,
the most significant peak, according to the q value of the peak-
calling analysis (SI Appendix, Fig. S1A), was the single peak in
the 3′-UTR of Ck1δ (SI Appendix, Fig. S1B), but no significant
peaks were detected in the mRNA of its close homolog, Ck1« (SI
Appendix, Fig. S1B). Given these observations, together with the
relevance of Ck1δ for human FASPS and its role as a hub kinase
(24), we selected Ck1δ for further investigations.
m6A Regulates the Expression of Two CK1δ Isoforms. To investigate
the role of m6A in the control of Ck1δ expression, we treated
mouse embryonic fibroblasts (MEFs) with Deazaneplanocin A
(DZnep), an inhibitor of methylation known to inhibit m6A and
elongate the circadian period length in these cells (14, 25), and
observed an increase in CK1δ proteins (Fig. 1A). This was op-
posite to our expectations, since available evidence published so
far in mammals has associated higher CK1δ expression with a
faster clock (26). While replicating these results, we noticed that,
under certain conditions during migration of proteins in the
acrylamide gel, two bands, not one, were seen on the membrane,
both bands increasing under DZnep treatment (Fig. 1A). By
comparing these two bands with the bands obtained from cells
transfected with CK1δ expression vectors, we later identified the
two bands as two isoforms of CK1δ (Fig. 3), CK1δ1 (415 aa) and
CK1δ2 (409 aa), reported in databases but of functions unknown,
sharing 99.75% identity with human CK1δs, and conserved in virtually
all vertebrates (SI Appendix, Fig. S1 C and D). The only difference
between these isoforms is a small 63-bp exon in mouse, retained in
Ck1δ2 immediately upstream of the 3′-UTR and containing a STOP
codon (SI Appendix, Fig. S1B), thus coding for the smaller kinase.
To confirm that the results above were dependent upon mRNA
m6A inhibition, we silenced in MEFs the catalytic subunit of the
mRNA m6A methyltransferase, Mettl3 (27, 28), and measured
CK1δ protein levels by immunoblotting. Again, two specific bands
were detected. Silencing of Mettl3 increased the intensity of the
two bands, demonstrating m6A negatively regulates CK1δ ex-
pression (Fig. 1B). At the mRNA level, Mettl3 silencing mildly
increased Ck1δ1 and had little effect on Ck1δ2 (Fig. 1C) and
significantly delayed the initial steps in Ck1δ1 and Ck1δ2 degra-
dation (SI Appendix, Fig. S2A). Surprisingly, the half-life of Ck1δ2
was significantly longer than that of Ck1δ1, which we confirmed in
a longer time course (SI Appendix, Fig. S2B).
Since the increase in CK1δs under m6A inhibition cannot be
readily explained by changes in steady-state transcript levels or
mRNA stability, we measured the impact of Mettl3 silencing on
translation of Ck1δ transcripts by polysome fractionation (Fig.






















































































































































































Fig. 1. Two Ck1δ alternative transcripts are under m6A control. (A) A 50-μMDZnep treatment for 2 h increased CK1δ protein levels, and two CK1δ isoforms were
observed when run on a 10% acrylamide gel. ACTIN was used as a loading control. (B) Mettl3 silencing increases CK1δ protein levels. Knock-down of METTL3 was
confirmed, and RPLP0 was used as a loading control. (Right) Quantification of the total intensity of CK1δ bands relative to RPLP0, analyzed by Student t test,
shown as mean ± SD, *P < 0.05. (C) Mettl3 silencing causes little changes in Ck1δ mRNA steady-state levels. Only Ck1δ1 showed a mild but significant increase.
Data for each transcript were analyzed by Student t test and are shown as mean ± SEM, n = 3, *P < 0.05. (D) Mettl3 silencing increases the translated fraction of
Ck1δ transcripts. (Top Right) Heatmap visualization of mean relative mRNA abundance for each transcript in each fraction. (Top Left) Quantification of transcripts
in input cytoplasmic lysates, showing significant knock-down of Mettl3 but no significant differences in Ck1δ1, Ck1δ2, Ck1«, and Rplp0 mRNA levels; ΔCT data,
analyzed by multiple t tests, are shown as mean ± SEM, n = 3, ***P < 0.001. (Bottom) Bar charts show mean ΔCT ± SEM of indicated transcripts in each fraction,
with significance levels in two-way ANOVA followed by Bonferroni post hoc test, n = 3, *P < 0.05, **P < 0.01, ***P < 0.001.








translation efficiency (29), Mettl3 silencing significantly increased
the amount of Ck1δ transcripts only in fractions containing the
heavier polysomes, while Ck1« was not significantly affected.
The 3′-UTR of Ck1δ transcripts is over 2,000 nucleotides long,
but its function in the regulation of CK1δ expression is unknown.
We designed reporter mRNAs in which the luciferase coding
sequence was flanked by the 5′- and 3′-UTRs of Ck1δ. To closely
mimic Ck1δ1 and Ck1δ2, the end of the coding sequence of each
Ck1δ was also included downstream of the luciferase STOP co-
don. We also designed Ck1δluc transcripts lacking most of the 3′-
UTR. These reporter mRNAs were transcribed in vitro and then
added to reticulocyte lysates to assess the efficiency of their
translation by luminometry (SI Appendix, Fig. S2C). The deletion
of the 3′-UTR caused a significant increase in Ck1δ1luc (ap-
proximately sixfold) and Ck1δ2luc (approximately threefold)
luminescence, demonstrating the role of the 3′-UTR as a nega-
tive regulator of CK1δ translation.
Ablation of Ck1δ m6A Methylation by CRISPR-Cas9 in Vivo. Next, to
investigate the physiological role of the methylated locus in the
3′-UTR of Ck1δ, we generated a mutant mouse strain with a 43-
bp deletion in the genomic region corresponding to the meth-
ylated peak (Fig. 2A). This deletion does not affect the coding
sequence but removes the N6-methylated adenosine at GGm6ACA,
located previously by screening of m6A sites in brain and liver
transcriptomes (30). The consequences of this mutation on Ck1δ
m6A levels, mRNA, and protein expression were investigated in the
liver, since it is known to have high mRNA m6A levels (2). As
expected, Ck1δ transcripts had lower m6A levels in −43/−43 ani-
mals compared with wild type (Fig. 2B), but the level of Ck1δ
mRNAs was not significantly affected (Fig. 2B). In contrast, CK1δ
protein levels increased significantly: homozygous −43 mutant mice
had higher CK1δ levels in the liver and the brain (Fig. 2C), despite
an inversed CK1δ1/CK1δ2 ratio (Fig. 3), and had a longer period
(23.97 h ± 0.02) of locomotor activity behavior rhythms compared
with wild-type mice (23.64 h ± 0.08, Fig. 2D). Although noncoding,
this mutation, weakening m6A-dependent posttranscriptional pro-
cesses limiting CK1δ expression, was sufficient to cause an observ-
able increase in CK1δ proteins, accompanied by a change in
circadian locomotor activity behavior. How an increase in the ex-
pression of endogenous CK1δs is able to elongate period length is
investigated in the next part of this work.
CK1δ1 and CK1δ2 Are Two Different Kinases. Data presented above
go against expectations based on period elongation observed in
liver explants from Ck1δ knock-out mice (31) and on CK1δ
overexpression causing a shorter period (26). The overexpression
studies, however, did not specify which isoform was used. The
existence of two isoforms has been suggested before in a circa-
dian context (32), but has been ignored until now. Surprisingly,
since CK1δ1 is considered canonical and has been the de facto
focus of past works, CK1δ2 is the major isoform in the liver,
where both transcripts show relatively constant levels across 24 h
(Fig. 3A). In the suprachiasmatic nucleus of the hypothalamus
(SCN), this relationship is reversed (Fig. 3B; see also Fig. 2C),
and the molar ratio of Ck1δ2/Ck1δ1 is tissue-specific (Fig. 3C).
Both CK1δs can interact with PER2 (Fig. 3D), but no evidence
of CK1δ1/CK1δ2/PER2 complexes was observed. To test the
role of CK1δs in the circadian clock, immortalized MEFs pre-
pared from PER2::LUCIFERASE knock-in reporter mice (33)
were stably transfected with CK1δ1 or CK1δ2 expression vectors.
Overexpression of CK1δ1 led to a shorter period (Fig. 3E)
compared with colonies stably transfected with the empty vector.
In contrast, CK1δ2 led to an ∼1-h period elongation. While both
isoforms could phosphorylate PER2 (Fig. 3F), the intensity of
the phosphorylated bands was higher with CK1δ2 and CK1δ1 +
CK1δ2, suggesting higher kinase activity for CK1δ2 and/or faster
PER2 degradation with CK1δ1. A picture emerges in which
CK1δ isoforms may not simply be two redundant kinases but may
phosphorylate PER2 differently and in cooperation.
Work on CK1δ and -e have shown that PER2 phosphorylation
can either accelerate or decelerate the clock depending on which
residue is targeted (15, 34, 35). pS478 in mice leads to faster
degradation of PER2 by the ubiquitin ligase β-Trcp (36–38),
while pS659, named FASPS because its mutation in humans
(S662G) causes FASPS, stabilizes PER2 and elongates period
(16, 18, 34, 38–40). S659 and three to four nearby downstream
residues are phosphorylated in vivo, but work in vitro using CK1e
or CK1δ has shown that CK1 needs a priming phosphorylation at
S659 by an unknown “priming” kinase before phosphorylating
downstream residues in the cluster, which is necessary for
PER2 stabilization. In vitro experiments concluding that CK1δ
could not phosphorylate S659, however, used a truncated CK1δ
containing only the N-terminal kinase domain and thus gave no
insights into the respective functions of CK1δ isoforms (41).
CK1δ1 and CK1δ2 Lead to Different PER2 Phosphorylation Patterns.
To gain insights into the respective functions of CK1δs, we refined
a previously published mathematical model of the regulation of
PER2 by branched phosphorylation fates (38) to allow the rate of
each phosphorylation step to be independently tuned (SI Appendix,
Fig. S3A). As explained in SI Appendix, Supplemental Results, our
model predicted that CK1δ2 could be the priming kinase. To test
this possibility, we transfected PER2::LUC MEFs with the vector
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Fig. 2. Deletion of m6A locus from Csnk1d 3′-UTR is sufficient to elongate
the circadian period in vivo. (A) Location of the mutation and genotyping of
mice bearing a −43 deletion in the Csnk1d gene. The region of the zoomed
m6A peak highlighted in red corresponds to the peak summit identified by
MACS2 peak calling analysis. (B) Quantification of Ck1δ mRNA m6A levels
(Left) and of Ck1δ1 and Ck1δ2 mRNA expression in the liver by qPCR (Right).
Analyzed by two-way ANOVA (wild type vs. −43, P < 0.0001, n = 3) followed
by Bonferroni post hoc, ***P < 0.001. (C, Left) Representative immuno-
blotting for CK1δ and loading control RPLP0 with liver samples. Mean ± SEM
quantification of CK1δ band intensity analyzed by Student t test is shown
below; n = 3, **P < 0.01. (C, Right) Representative immunoblotting for CK1δ
and loading control RPLP0 with n = 2 brain samples. (Bottom) Mean ± SEM
quantification of data aggregated from three independent experiments for
a total of n = 6 animals, analyzed by Student t test; *P < 0.05. (D) Circadian
locomotor activity recording from one representative animal of each ge-
notype is shown. (Right) Period was analyzed by χ2 periodogram; mean
period ± SEM was analyzed by Student t test of n = 6 animals.
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quantified PER2 phosphopeptides after trypsin digestion. Tetra-,
tri, di-, and unphosphorylated FASPS peptides were detected (Fig.
4A, SI Appendix, Fig. S4, and Dataset S2). The amount of
unphosphorylated FASPS peptide was highest without CK1δs, and
lowest with CK1δs together. The diphosphorylated peptide, always
detected without pS659, had similar levels with or without CK1δs.
The level of triphosphorylated peptides showed some variations
between replicates but was always highest when both CK1δ1 and
CK1δ2 were present. Remarkably, the tetraphosphorylated
FASPS peptide, with confirmed pS659 (SI Appendix, Fig. S4B),
showed the most pronounced isoform-dependent differences in
abundance among all PER2 phosphopeptides detected (SI Ap-
pendix, Fig. S4A and Dataset S2). It was undetected without CK1δ
F
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CK11    -    1   -  0.5
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1: 1-HA : 2-MYC : P2 1:1:1
2: 1-HA : 2-MYC : P2 1:1:3
3: 1-MYC : 2-HA : P2 1:1:1
4: 1-MYC : 2-HA : P2 1:1:3
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Fig. 3. CK1δ1 and CK1δ2 are antagonistic. Ck1δ1 and Ck1δ2 mRNA levels in
the liver (A) and the SCN (B) across a circadian day, with opposite Ck1δ2/Ck1δ1
ratios mainly due to different levels of Ck1δ1. Mean ± SEM analyzed by two-
way ANOVA, n = 3, significant for Ck1δ1 vs. Ck1δ2 (P < 0.0001) and for time,
only in the liver for Ck1δ2 (P < 0.05). (C) Tissue-specific Ck1δ2/Ck1δ1 ratios
measured in six different tissues. Analyzed by one-way ANOVA, P < 0.0001,
followed by Bonferroni post hoc, a vs. b vs. c vs. d, indicating at least P <
0.05 significance. Results shown are mean ± SD of n = 2. (D) Coimmuno-
precipitation shows that both CK1δ1-HA and CK1δ2-HA interact with
5xMYC-PER2. Two CK1δ1-tag:CK1δ2-tag:5xMYC-PER2 ratios were used at
1:1:1 and 1:1:3. (E ) Stable overexpression of CK1δ1 and CK1δ2 in PER2::LUC
MEFs leads to period shortening and lengthening, respectively. (Inset) Pe-
riod analyzed by one-way ANOVA, P < 0.001, with a vs. b vs. c in Bonferroni
post hoc at least P < 0.05; results shown are mean ± SEM of n = 4 mono-
clonal cell lines for each group. (Top) CK1δ and ACTIN immunoblots for
each cell line. (F) Cotransfection of 5xMYC-PER2 with untagged CK1δ1 and/
or CK1δ2 shows higher 5xMYC-PER2 phosphorylation (and/or higher sta-
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CK1 protein amounts (arbitrary units from immunoblot)
CK12
CK11
Fig. 4. CK1δ1 and CK1δ2 cooperate in phosphorylating PER2. (A) CK1δ
isoform-dependent PER2 FASPS phosphopeptides analysis. Data from two
technical replicates are provided, side by side. CK1δ peptides were also de-
tected: the first row shows total CK1δ, and the second row corresponds to
the CK1δ1-specific VASSGLQSVVHR peptide. The 4 × 4 heatmaps show
quantification of the FASPS peptide, sorted by number of phosphate moi-
eties detected. The bar on the Right is the color legend for each corre-
sponding heatmap. (B) Immunoblotting of hPER2 FASPS phosphorylation by
CK1δ isoforms. CK1δ and actin immunoblotting are shown as reference and
loading control, respectively. Graph on the Right shows mean FASPS band
intensity ± SEM of n = 4 independent replicate wild-type hPER2 transfections
with CK1δ1, CK1δ2, and 1 + 2. *P < 0.05; **P < 0.01. (C) mPER2 was
expressed in HEK293 cells in the presence of increasing amounts of vectors
(10, 25, 50 ng) encoding CK1δ splice variants as indicated. Forty-eight hours
after transfection, lysates were probed with anti-pS659 mPER2, anti-Myc,
and anti-tubulin antibodies. (Bottom) The ratio of pS659/total PER2 as a
function of CK1δ amounts.








and highest when CK1δs were transfected together, indicating that
both isoforms are required for full FASPS phosphorylation.
Next, we confirmed the results above with immunoblotting using
an anti-triphospho FASPS antibody (39). Since this antibody was
raised against the human FASPS sequence, we used an untagged
human PER2 (hPER2) expression vector. The phosphorylated
FASPS cluster was not detected when hPER2 was transfected
alone (Fig. 4B), indicating that endogenous kinases are not suffi-
cient to noticeably phosphorylate exogenous PER2 (same with Figs.
3F and 4A). When transfected with CK1δ1, a new band appeared
corresponding to FASPS phosphorylation. This band increased in
intensity with CK1δ2 and with CK1δ1 + CK1δ2. Validating these
results, CK1δs mutated to K38R, which has been reported to blunt
kinase activity (42), were unable to normally phosphorylate the
FASPS cluster (Fig. 4B). In addition, wild-type CK1δs could not
phosphorylate a S662G-mutated hPER2. Together, these data
demonstrate that CK1δ1 and CK1δ2 cooperate in the phosphory-
lation of PER2, with CK1δ2 promoting FASPS phosphorylation.
Next, the activity of CK1δs on the phosphorylation of S659 in
mouse PER2 was investigated. To validate our results in-
dependently, we transfected HEK293 cells with different vectors
encoding myc-tagged CK1δ1 or CK1δ2, together with myc-
tagged mPER2, and probed cell lysates with a novel antibody
specifically raised against pS659 (43). Despite lower exogenous
expression of CK1δ2, these data revealed clearly that the activity
of CK1δ2 on S659 is remarkably higher than that of CK1δ1 (Fig.
4C). Together, these data demonstrate that the activity of
CK1δ2 as a priming kinase is higher than that of CK1δ1, but that
both isoforms are required for the full phosphorylation of the
FASPS cluster.
Lack of CK1δ2 Shortens the Period. We next sought to silence en-
dogenous Ck1δ2 by siRNA in PER2::LUC MEFs. While Ck1δs
knock-down elongated the circadian period in a manner consistent
with previous observations (31), silencing only Ck1δ2 significantly
shortened the period (Fig. 5A).
The effect of Ck1δ2 knock-down on endogenous FASPS
phosphorylation and PER2 levels was also measured. Knocking
down Ck1δ2 in human U-2 OS cells caused an observable decrease
in FASPS, despite CK1δ1 being still present. To ascertain that the
band that we detected is truly FASPS-phosphorylated endogenous
PER2, as positive controls Ck1δs and Per2 were also silenced, leading,
as expected, to a decrease in the FASPS band intensity. In addition,
diluted lysate of cells transfected with wild-type or S662G mutant
hPER2 expression vector, with or without CK1δ expression vectors,
confirmed the identity of the endogenous FASPS band (Fig. 5B).
According to our results so far, the consequences of PER2
phosphorylation by CK1δ1 or CK1δ2 on PER2 stability should be
different: more stable when phosphorylated by CK1δ2 than by
CK1δ1 due to increased FASPS phosphorylation. We tested this
by transfecting hPER2 together with CK1δ1 or CK1δ2 and then
treating the cells with the translation inhibitor cycloheximide
(CHX). PER2 stability was highest without cotransfected CK1δ
(Fig. 5C). When comparing CK1δ1 vs. CK1δ2, not only the in-
tensity of phosphorylated PER2 was higher with CK1δ2, as ob-
served in Fig. 3F, but the stability of total PER2 was higher in the
presence of CK1δ2 (Fig. 5C), which explains the former obser-
vation. Surprisingly, CK1δ2 did not stabilize transfected hPER2 as
expected. Since the large amounts of transfected vectors may af-
fect normal regulation or PER2 proteins, we sought to investigate
the stability of PER2::LUC proteins in stably transfected cells
described in Fig. 3E. These control, CK1δ1-, and CK1δ2-over-
expressing PER2::LUC cell lines were synchronized by a dexa-
methasone shock, and after ∼30 h (time of the first PER2 peak),
were treated with CHX to assess PER2::LUC stability. In agree-
ment with our hypothesis, while CK1δ1 destabilized PER2::LUC,
CK1δ2 had a remarkable effect on its stabilization (Fig. 5C).
Finally, we sought to confirm that the long-period phenotype of
the −43/−43 mice originates from a more stable PER2 protein due
to an increase in CK1δ (2) expression. Primary skin fibroblasts were
prepared from adult −43/−43 and wild-type mice, synchronized, and
then treated after 30 h with CHX and sampled every hour to mea-
sure PER2 stability. Consistent with previous observations, −43/−43
cells had increased CK1δ expression compared with wild type, both
wild-type and −43 cells mostly expressing CK1δ2 (Fig. 5D). In
agreement with our hypothesis, PER2 was more stable in −43/−43
cells (Fig. 5D).
Discussion
We have shown that two alternative Ck1δ transcripts are regu-
lated by m6A. When the methylation of Ck1δ 3′-UTR is
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Fig. 5. CK1δ2 stabilizes PER2 and slows the clock. (A) Silencing of Ck1δ2 leads
to short period, while silencing of both Ck1δs leads to long period. Knock-
down efficiency of Ck1δ and Ck1δ2 was first confirmed by immunoblotting
(Top). Main graph showsmean± SEM of real-time luminometry traces for each
group; n = 2. (Right Inset) Mean period ± SEM analyzed by one-way ANOVA,
P < 0.0001. a vs. b vs. c, at least P < 0.01 in Bonferroni post hoc. (B) Silencing of
endogenous Ck1δ2 in human U-2 OS cells is sufficient to decrease FASPS
phosphorylation, as identified by immunoblotting. The identity of the FASPS
band was confirmed by transfection of mutated or wild-type expression vec-
tors. (C) The stability of hPER2 phosphorylated by CK1δ2 is higher than that of
CK1δ1-phosphorylated hPER2, measured in transiently transfected cells. Rep-
resentative PER2, CK1δ, and ACTIN immunoblots are shown. (Bottom Left)
Mean relative band intensity ± SEM of total PER2, analyzed by two-way
ANOVA, all sources of variations at least P < 0.01, n = 3; *at least P < 0.05 in
Bonferroni’s post hoc. (Bottom Right) The effect of CK1δs on PER2::LUC sta-
bility in the stably transfected cell lines used in Fig. 3E, showing mean rela-
tive luminescence ± SEM, analyzed by two-way ANOVA, with all sources of
variations P < 0.0001, n = 6. The grayed area shows where significance reached
P < 0.0001 between cell lines in Bonferroni’s post hoc test. (D) PER2 is more
stable in −43/−43 primary adult skin fibroblasts than in wild type, consistent
with higher CK1δ expression, represented mainly by CK1δ2 in these cells. The
lower ACTIN signal from −43/−43 cells was due to lower cell counts at the time
of sampling, i.e., mean ± SD, 3.68 ± 0.15 × 105 for −43/−43 cells versus 4.42 ±
0.27 × 105 for wild type. (Bottom Left) Quantification of the entire PER2 signal
at 0, 1, 2, 4, and 6 h after CHX from n = 3 experiments and analyzed by two-
way ANOVA followed by Bonferroni post hoc; *P < 0.05; **P < 0.01; ***P <
0.001. (Bottom Right) CK1δ/ACTIN signal ratio averaged across the entire time
course shown above, with the relative intensity in wild type for each time
point equal to 1.
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isoforms increases, affecting the circadian clock. It is likely, given
that Dbp, Fbxl3, and Clock transcripts are also methylated, that
global inhibition of mRNA m6A methylation would still affect
the clock in −43/−43 animals, as the general disruption of
mRNA processing caused by the lack of m6A would still occur.
While the lack of CK1δ is embryonic lethal (31), higher ex-
pression or increased activity has been linked to cancer progres-
sion, migraine, and circadian disruption (24). As we demonstrated
here, the expression of CK1δ isoforms is kept to a low level by its
methylated 3′-UTR. The significance of these observations goes
beyond the circadian field, given the manifold functions of CK1δ.
Further investigations should reveal what the respective physio-
logical functions of CK1δ isoforms are, and additional discussion
on the role and regulation of CK1Ds can be found in SI Appendix,
Supplemental Discussion.
Materials and Methods
Reagents were from Nacalai Tesque unless stated otherwise.
Animals. All experiments were approved by the animal experimentation
committee of Kyoto University. Twelve-week-old C57BL/6 males were main-
tained at 23 °C ± 1 °C with 50% ± 10% relative humidity, on a 12-h light/12 h
dark cycle (lights on 8:00, lights off 20:00), food and water ad libitum. For Fig.
3 A and B, lights were permanently switched off from 8 PM on day 0, and
animals were sampled from 8 AM (corresponding to circadian time 0) on day 2.
Mice with a −43-bp deletion in the 3′-UTR of Csnk1d by CRISPR-Cas9 were
generated with the same method used for similar genetic editing (44) as
briefly explained in SI Appendix, Supplemental Methods. Locomotor activity
recording and analysis were obtained from animals housed individually in
light-tight, ventilated cages with ad libitum access to food and water. The
animals were entrained on a 12-h light (∼200 lx fluorescent light)/12-h dark
cycle for at least 1 wk to synchronize the circadian clock to the ambient
light–dark cycle, before turning lights off for the remainder of the experi-
ment. Locomotor activity was recorded in 5-min bins with passive infrared
sensor (FA-05 F5B; Omron) and analyzed with Clocklab software (Acti-
metrics) on MatLab (Mathworks). Free-running period was quantified by χ2
periodogram over the entire recording in constant darkness.
In Vitro Experiments. All in vitro experiments are described in SI Appendix,
Supplemental Methods.
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